10
Participants
Start Date
January 6, 2020
Primary Completion Date
March 28, 2022
Study Completion Date
March 28, 2022
Diffusing Alpha-emitter Radiation Therapy
Diffusing Alpha-emitter Radiation Therapy (DaRT) is a method of delivering interstitial brachytherapy, based on the interstitial intratumoral placement of an encapsulated Radium-224 source (3.7 days half-life). These sources release short-lived alpha-emitting atoms into the tumor microenvironment by recoil. As the radioisotope has a short half-life, the majority of radiation absorption happens in the tumor.
Memorial Sloan-Kettering Cancer Center, New York
West Cancer Center & Research Institute, Germantown
UnityPoint Health - John Stoddard Cancer Center, Des Moines
University Cancer & Diagnostic Center, Houston
Dermatology of Seattle and Bellevue, Seattle
Lead Sponsor
Alpha Tau Medical LTD.
INDUSTRY